Status:
NOT_YET_RECRUITING
The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Overdose, Drug
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to develop and test the CROSSROADS intervention. CROSSROADS is designed for people who have recently survived an opioid and/or stimulant-related non-fatal overdose a...
Detailed Description
CROSSROADS is a Hybrid Type I Implementation Effectiveness Trial. The primary objective of the study is to examine how the CROSSROADS intervention, which incorporates a Medical-Legal Partnership (MLP)...
Eligibility Criteria
Inclusion
- 18 years old or older;
- Has interacted with a CP team (and, thus, experienced a non-fatal opioid and/or stimulant overdose) in the last 30 days;
- Has independent legal agency
- Able to independently provide informed consent; and
- Able to speak and understand English.
Exclusion
- \- Active, severe, and untreated mental illness that would make providing consent impossible
Key Trial Info
Start Date :
September 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2030
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07216963
Start Date
September 1 2026
End Date
August 1 2030
Last Update
November 14 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33146
2
Boston Medical Center
Boston, Massachusetts, United States, 02118
3
Duke University
Durham, North Carolina, United States, 27701
4
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260